Who Buys Burnol from India — 140 Importers Behind a $64.9K Market

Burnol, a topical antiseptic cream, has been exported from India to 30 countries, involving 140 buyers and totaling $0.1 million across 234 shipments. The repeat buyer rate stands at 35.0%, indicating a moderate level of recurring demand. The average unit price is $18.45, classified under HS Code 30049099.

Buyer Segments:

1. Distributors: These entities purchase Burnol in bulk to supply to various retailers, pharmacies, and healthcare providers within their respective countries. Their buying behavior typically involves large, periodic orders to maintain inventory levels and meet market demand. Given the repeat buyer rate of 35.0%, a portion of these distributors likely engage in regular procurement cycles.

2. Retail Chains: Large pharmacy chains or supermarkets that import Burnol directly to stock their shelves fall into this category. Their order patterns are influenced by consumer demand, promotional activities, and seasonal trends. They may place smaller, more frequent orders compared to distributors to optimize inventory turnover.

3. Re-exporters: Some buyers import Burnol with the intent to re-export to neighboring countries or regions. This segment's purchasing behavior is characterized by strategic bulk buying, aiming to capitalize on price differentials and market opportunities in other territories.

4. Government Procurement Agencies: Entities such as national health departments or organizations like UNICEF and the Global Fund may procure Burnol for public health initiatives. Their orders are typically large and tied to specific health programs or emergency response efforts.

5. Hospital Groups: Large hospital networks may import Burnol directly for use within their facilities. Their purchasing patterns are steady, based on patient needs and institutional formularies.

6. Contract Manufacturers: Companies that import Burnol as a component for further processing or repackaging under different brand names. Their buying behavior depends on contractual obligations and production schedules.

Top Buyers:

Among the top 10 buyers, D JARO CONSUMERS GOODS TRADING from the Philippines is notable. While specific classifications for each top buyer are not detailed in the provided data, it's reasonable to infer that they predominantly fall into the distributor and retail chain segments, given the nature of Burnol as an over-the-counter product.

1. Australia:

• Drug Regulatory Authority: Therapeutic Goods Administration (TGA).

• Import Registration Process: Burnol must be listed in the Australian Register of Therapeutic Goods (ARTG). The sponsor submits an application to the TGA, including evidence of product quality, safety, and efficacy.

• Estimated Timeline for Registration: The evaluation process can take approximately 6 to 12 months, depending on the completeness of the application and the product's risk classification.

• Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally duty-free in Australia.

2. United Arab Emirates (UAE):

• Drug Regulatory Authority: Ministry of Health and Prevention (MOHAP).

• Import Registration Process: Importers must register the product with MOHAP by submitting detailed documentation, including product composition, manufacturing processes, and labeling.

• Estimated Timeline for Registration: The registration process typically takes 6 to 9 months.

• Import Tariff/Duty for HS 30049099: Medicaments under HS code 30049099 are subject to a 0% import duty in the UAE.

3. United States:

• Drug Regulatory Authority: Food and Drug Administration (FDA).

• Import Registration Process: Burnol must be registered with the FDA. The importer must ensure compliance with FDA regulations, including facility registration and product listing.

• Estimated Timeline for Registration: The registration process can take several months, depending on the complexity of the product and the completeness of the submission.

• Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally duty-free in the United States.

4. Singapore:

• Drug Regulatory Authority: Health Sciences Authority (HSA).

• Import Registration Process: Importers must obtain approval from the HSA by submitting a product registration application, including data on product quality, safety, and efficacy.

• Estimated Timeline for Registration: The evaluation process typically takes 9 to 12 months.

• Import Tariff/Duty for HS 30049099: Medicaments under HS code 30049099 are generally duty-free in Singapore.

5. Canada:

• Drug Regulatory Authority: Health Canada.

• Import Registration Process: Burnol must be approved by Health Canada. The importer submits a New Drug Submission (NDS) or an Abbreviated New Drug Submission (ANDS), depending on the product's status.

• Estimated Timeline for Registration: The review process can take 12 to 18 months.

• Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally duty-free in Canada.

The demand for Burnol in importing countries is influenced by several factors:

1. Burn and Wound Incidence: Countries with higher rates of burns and minor injuries drive the demand for topical antiseptics like Burnol. For instance, the World Health Organization (WHO) reports that burn injuries are a significant public health problem in many low- and middle-income countries.

2. Government Healthcare Programs: National health initiatives focusing on emergency care and first aid promote the use of products like Burnol. In countries with universal health coverage expansion, there is an increased procurement of essential medicines, including topical antiseptics.

3. WHO Essential Medicines List (EML) Procurement: Burnol's active ingredients may be listed in the WHO EML, leading to its inclusion in bulk purchasing agreements by governments and international organizations.

4. Tender-Based Purchasing: Many countries procure pharmaceuticals through tender systems. Burnol's inclusion in such tenders, especially in regions with high burn injury rates, presents significant market opportunities.

With 140 buyers across 30 countries, the market for Burnol demonstrates a broad international reach. The moderate repeat buyer rate of 35.0% suggests potential for growth, particularly in markets with expanding healthcare access and increasing awareness of burn care management.

Burnol, a topical antiseptic cream, has been exported from India to 30 countries, involving 140 buyers and totaling $0.1 million across 234 shipments. The repeat buyer rate stands at 35.0%, indicating a moderate level of recurring demand. The average unit price is $18.45, classified under HS Code 30049099.

Buyer Segments:

1. Distributors: These entities purchase Burnol in bulk to supply to various retailers, pharmacies, and healthcare providers within their respective countries. Their buying behavior typically involves large, periodic orders to maintain inventory levels and meet market demand. Given the repeat buyer rate of 35.0%, a portion of these distributors likely engage in regular procurement cycles.

2. Retail Chains: Large pharmacy chains or supermarkets that import Burnol directly to stock their shelves fall into this category. Their order patterns are influenced by consumer demand, promotional activities, and seasonal trends. They may place smaller, more frequent orders compared to distributors to optimize inventory turnover.

3. Re-exporters: Some buyers import Burnol with the intent to re-export to neighboring countries or regions. This segment's purchasing behavior is characterized by strategic bulk buying, aiming to capitalize on price differentials and market opportunities in other territories.

4. Government Procurement Agencies: Entities such as national health departments or organizations like UNICEF and the Global Fund may procure Burnol for public health initiatives. Their orders are typically large and tied to specific health programs or emergency response efforts.

5. Hospital Groups: Large hospital networks may import Burnol directly for use within their facilities. Their purchasing patterns are steady, based on patient needs and institutional formularies.

6. Contract Manufacturers: Companies that import Burnol as a component for further processing or repackaging under different brand names. Their buying behavior depends on contractual obligations and production schedules.

Top Buyers:

Among the top 10 buyers, D JARO CONSUMERS GOODS TRADING from the Philippines is notable. While specific classifications for each top buyer are not detailed in the provided data, it's reasonable to infer that they predominantly fall into the distributor and retail chain segments, given the nature of Burnol as an over-the-counter product.

1. Australia:

• Drug Regulatory Authority: Therapeutic Goods Administration (TGA).

• Import Registration Process: Burnol must be listed in the Australian Register of Therapeutic Goods (ARTG). The sponsor submits an application to the TGA, including evidence of product quality, safety, and efficacy.

• Estimated Timeline for Registration: The evaluation process can take approximately 6 to 12 months, depending on the completeness of the application and the product's risk classification.

• Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally duty-free in Australia.

2. United Arab Emirates (UAE):

• Drug Regulatory Authority: Ministry of Health and Prevention (MOHAP).

• Import Registration Process: Importers must register the product with MOHAP by submitting detailed documentation, including product composition, manufacturing processes, and labeling.

• Estimated Timeline for Registration: The registration process typically takes 6 to 9 months.

• Import Tariff/Duty for HS 30049099: Medicaments under HS code 30049099 are subject to a 0% import duty in the UAE.

3. United States:

• Drug Regulatory Authority: Food and Drug Administration (FDA).

• Import Registration Process: Burnol must be registered with the FDA. The importer must ensure compliance with FDA regulations, including facility registration and product listing.

• Estimated Timeline for Registration: The registration process can take several months, depending on the complexity of the product and the completeness of the submission.

• Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally duty-free in the United States.

4. Singapore:

• Drug Regulatory Authority: Health Sciences Authority (HSA).

• Import Registration Process: Importers must obtain approval from the HSA by submitting a product registration application, including data on product quality, safety, and efficacy.

• Estimated Timeline for Registration: The evaluation process typically takes 9 to 12 months.

• Import Tariff/Duty for HS 30049099: Medicaments under HS code 30049099 are generally duty-free in Singapore.

5. Canada:

• Drug Regulatory Authority: Health Canada.

• Import Registration Process: Burnol must be approved by Health Canada. The importer submits a New Drug Submission (NDS) or an Abbreviated New Drug Submission (ANDS), depending on the product's status.

• Estimated Timeline for Registration: The review process can take 12 to 18 months.

• Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are generally duty-free in Canada.

The demand for Burnol in importing countries is influenced by several factors:

1. Burn and Wound Incidence: Countries with higher rates of burns and minor injuries drive the demand for topical antiseptics like Burnol. For instance, the World Health Organization (WHO) reports that burn injuries are a significant public health problem in many low- and middle-income countries.

2. Government Healthcare Programs: National health initiatives focusing on emergency care and first aid promote the use of products like Burnol. In countries with universal health coverage expansion, there is an increased procurement of essential medicines, including topical antiseptics.

3. WHO Essential Medicines List (EML) Procurement: Burnol's active ingredients may be listed in the WHO EML, leading to its inclusion in bulk purchasing agreements by governments and international organizations.

4. Tender-Based Purchasing: Many countries procure pharmaceuticals through tender systems. Burnol's inclusion in such tenders, especially in regions with high burn injury rates, presents significant market opportunities.

With 140 buyers across 30 countries, the market for Burnol demonstrates a broad international reach. The moderate repeat buyer rate of 35.0% suggests potential for growth, particularly in markets with expanding healthcare access and increasing awareness of burn care management.